Endothelial monocyte-activating polypeptide-2 is increased in pregnancy but is not further increased in preeclampsia

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 3, 1999, Pages 142-146

  Wellings, Robert P ^a   Lash, Gendie E ^a   Murray, J Clifford ^b   Tas, Maarten ^b   Ward, Wynne ^b   Trew, Alison J ^a   Baker, Philip N ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Division of Clinical Oncology Sch Clin Lab Sci Nottingham C   (United Kingdom)

Author keywords

Cytokine; Endothelial monocyte activating polypeptide 2; Preeclampsia; Pregnancy

Indexed keywords

CYTOKINE; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MONOCYTE; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033039510     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00011-8     Document Type: Article

References (20)

1. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Pre-eclampsia an endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
2. Rodgers G. Hemostatic properties of normal and perturbed vascular cells. FASEB J. 2:1988;116-123.
3. McCartney C.P. The acute hypertensive disorders of pregnancy classified by renal histology. Gynaecologia. 167:1969;214-220.
4. Brown M.A., Zammit V.C., Lowe S.A. Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci. 77:1989;599-604.
5. Roberts J.M., Edep M.E., Goldfein A., Taylor R.N. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro. Am J Reprod Immunol. 27:1992;101-108.
6. Taylor R.N., Crombleholme W.R., Friedman S.A., Jones L.A., Casal D.C., Roberts J.M. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol. 165:1991;895-901.
7. Roberts J.M., Redman C. Pre-eclampsia More than pregnancy-induced hypertension . Lancet. 341:1993;1447-1451.
8. Baker P.N., Davidge S.T., Roberts J.M. Plasma from preeclamptic women increases endothelial cell nitric oxide production. Hypertension. 26:1995;244-248.
9. Ashworth J.R., Baker P.N., Warren A.Y., Johnson I.R. Loss of endothelium dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol. 104:1997;1152-1158.
10. Greer I.A., Haddad N.G., Dawes J., Johnstone F.D., Calder A.A. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 96:1989;978-982.
11. Kao J., Ryan J., Brett J., et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem. 267:1992;20239-20247.
12. Tas M.P., Houghton J., Jakobsen A.M., Tolmachova T., Carmichael J., Murray J.C. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor. Cytokine. 9:1997;535-539.
13. Tas M.P.R., Murray J.C. Endothelial-monocyte-activating polypeptide II. Int J Bio Cell Biol. 28:1996;837-841.
14. Kao J., Houck K., Fan Y., et al. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem. 269:1994;25106-25119.
15. Kao J., Fan Y.G., Haehnel I., et al. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response. J Biol Chem. 269:1994;9774-9782.
16. Schwarz M., Brett J., Li J., et al. Endothelial-monocyte activating polypeptide (EMAP) II, a novel antiangiogenic protein, suppresses tumor growth and induces apoptosis in endothelial cells. Circulation. 92:1995;1-7.
17. Smith S.C., Baker P.N., Symonds E.M. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol. 177:1997;1395-1401.
18. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Sharp F., Symonds E.M. Hypertension in pregnancy. Proceedings of the 16th study group of the RCOG. 1986;401-407 Perinatology Press, Ithaca, New York.
19. Wilcox M.A., Johnson I.R., Maynard P.V., Smith S.J., Chilvers C.E.D. The individualised birthweight ratio A more logical outcome measure of pregnancy than birthweight alone . Br J Obstet Gynaecol. 100:1993;342-347.
20. Chard T. Cytokines in implantation. Hum Reprod Update. 1:1995;385-396.